...
机译:BRD4抑制是通过诱导同源重组缺乏的PARP抑制剂的合成致死
Huazhong Univ Sci &
Technol Tongji Med Coll Tongji Hosp Dept Obstet &
Gynecol Wuhan 430030;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
Huazhong Univ Sci &
Technol Tongji Med Coll Tongji Hosp Dept Obstet &
Gynecol Wuhan 430030;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Bioinformat &
Computat Biol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Invest Canc Therapeut Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Invest Canc Therapeut Houston TX 77030 USA;
AstraZeneca IMED Oncol 35 Gatehouse Dr Waltham MA 02451 USA;
AstraZeneca 1 Francis Crick Ave Cambridge Biomed Campus Cambridge CB2 0RE England;
AstraZeneca IMED Oncol 35 Gatehouse Dr Waltham MA 02451 USA;
AstraZeneca IMED Oncol 35 Gatehouse Dr Waltham MA 02451 USA;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Clin Canc Prevent Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
机译:BRD4抑制是通过诱导同源重组缺乏的PARP抑制剂的合成致死
机译:妇科癌症的新靶向药物:合成致死性,同源重组缺陷和PARP抑制剂
机译:胆道癌症和同源重组缺乏的基因组改变:利用PARP抑制剂利用合成致死性
机译:炭疽致死毒素的强合成抑制剂
机译:针对VHL的损失:诱导化学合成杀伤力。
机译:BRD4抑制通过诱导同源重组缺陷与PARP抑制剂合成致死
机译:BRD4抑制是通过诱导同源重组缺乏的PARP抑制剂的合成致死
机译:BRCa1和BRCa2中未知显着性变异的功能分析与paRp抑制的合成致死相互作用的互补。